Target intelligence / Profile preview

Nucleosome assembly protein 1-like 2, pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

Nucleosome assembly protein 1-like 2, pseudogene (ENSG00000267088) is a non-coding genomic DNA sequence that resembles the protein-coding gene NAP1L2 but does not produce a functional protein product. Pseudogenes are considered non-functional remnants of genes that have accumulated mutations and are usually not transcribed or translated. This pseudogene is not associated with any known biological function, disease relevance, or therapeutic activity, and does not serve as a drug target[1][5][8]. For reference: the protein-coding gene "Nucleosome assembly protein 1-like 2" (NAP1L2, ENSG00000186462) is a member of the nucleosome assembly protein (NAP) family, involved in chromatin binding and regulation of neuronal cell proliferation[8]. However, the entity you specified (ENSG00000267088) is a pseudogene and thus does not encode that functional activity. Summary: “Nucleosome assembly protein 1-like 2, pseudogene” is not a valid therapeutic target; it is a non-functional pseudogene and should not be used as a target for drug or biomarker development[1][5][8].

Beyond the preview

Go deeper on Nucleosome assembly protein 1-like 2, pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleosome assembly protein 1-like 2, pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call